Workboat Indexes

Viatris Inc (NQ: VTRS )

11.38 +0.05 (+0.44%)

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist

Price and Volume

Volume	4,219,439
Open	11.37
Bid (Size)	11.32 (3)
Ask (Size)	11.42 (2)
Prev. Close	11.33
Today's Range	11.31 - 11.45
52wk Range	8.740 - 13.62
Shares Outstanding	1,212,301,241
Dividend Yield	4.22%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

October 01, 2024

How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Via News Direct

Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?

September 24, 2024

Regeneron filed an appeal after a court's decision, which was issued under seal.

Via Benzinga

Performance

YTD	-0.09%	-0.09%
1 Month	-3.15%	-3.15%
3 Month	+3.45%	+3.45%
6 Month	+0.53%	+0.53%
1 Year	+21.97%	+21.97%

More News

EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching

September 20, 2024

Via Benzinga

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

September 06, 2024

Via Benzinga

Peering Into Viatris's Recent Short Interest

May 27, 2024

Via Benzinga

Looking Into Viatris's Recent Short Interest

March 15, 2024

Via Benzinga

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production

September 06, 2024

Via Benzinga

3 Top Value Stocks to Buy Right Now

August 20, 2024

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session

August 15, 2024

Via Benzinga

US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs

August 08, 2024

Via Benzinga

Why Viatris Stock Is Jumping Today

August 08, 2024

Via The Motley Fool

Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs

August 06, 2024

Via Benzinga

3 Surprisingly Underrated Stocks to Buy Right Now

July 26, 2024

Via The Motley Fool

Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?

July 21, 2024

Via Benzinga

S&P 500 Four Under Five

June 28, 2024

Via Talk Markets

Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast

May 09, 2024

Via Benzinga

Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?

May 09, 2024

Via Benzinga

VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024

May 09, 2024

Via InvestorPlace

BTIG Research Predicts Over 118% Rally for These 3 Stocks

April 15, 2024

Via InvestorPlace

Steady Returns Ahead: 3 Dividend Stocks for Stable Income in Q2

April 03, 2024

Via InvestorPlace

Is Viatris a Great Dividend Stock or Just a Value Trap?

March 14, 2024

Via The Motley Fool

2 Dirt Cheap Dividend Stocks to Buy and Hold

March 11, 2024

Via The Motley Fool

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

March 11, 2024

From Scott+Scott Attorneys at Law and Hedin Hall LLP

Via Business Wire

Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?

February 28, 2024

Via Benzinga

Earnings Scheduled For February 28, 2024

February 28, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.